We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sloning BioTechnology Successfully Generated a Unique Type of Gene Mutant Library for Novozymes
News

Sloning BioTechnology Successfully Generated a Unique Type of Gene Mutant Library for Novozymes

Sloning BioTechnology Successfully Generated a Unique Type of Gene Mutant Library for Novozymes
News

Sloning BioTechnology Successfully Generated a Unique Type of Gene Mutant Library for Novozymes

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Sloning BioTechnology Successfully Generated a Unique Type of Gene Mutant Library for Novozymes"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sloning BioTechnology GmbH, the provider of enabling technologies for protein engineering applications, has successfully synthesised a unique gene mutant library (SlonoMax™ - Screen) for Novozymes A/S.

Sloning utilised its unique Slonomics™ gene synthesis technology to introduce several individual codons at specific positions of a gene sequence in a clearly defined ratio.

Novozymes will now use the library for screening applications to identify enzymes with significantly improved characteristics.

“We are very delighted by this collaboration with Novozymes. It gives Sloning the opportunity to demonstrate its capabilities in generating genetic diversity without limitations” stated Dr. Jan Van den Brulle, Head of R&D at Sloning.

Torben V. Borchert, Director of Protein Optimisation at Novozymes commented, “We are impressed by Sloning’s ability to precisely meet our sophisticated design specifications. We are very excited to learn how the use of such new types of designed libraries will influence our protein optimization processes”.

Advertisement